Oscient’s Factive Clears FDA For Five-Day Community Acquired Pneumonia Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Antibiotic is the only fluoroquinolone approved in the U.S. for five-day treatment of both CAP and AECB.